Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: A nested case-control study from the Pittsburgh epidemiology of diabetes complications study

Diabetes

Volumn 48, Issue 7, 1999, Pages 1454-1458

  Orchard, Trevor J ^a,e   Virella, Gabriel ^d   Forrest, Kimberly Y Z ^c   Evans, Rhobert W ^a   Becker, Dorothy J ^b   Lopes Virella, Maria F ^d  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c SLIPPERY ROCK UNIVERSITY   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; ENZYME IMMUNOASSAY; FEMALE; HEART INFARCTION; HUMAN; IMMUNOELECTROPHORESIS; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; CHILD; CORONARY DISEASE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FOLLOW-UP STUDIES; GLYCOSYLATION; HUMANS; LIPOPROTEINS, LDL; MULTIVARIATE ANALYSIS; OXIDATION-REDUCTION; PENNSYLVANIA; RISK FACTORS;

EID: 0033030997     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.7.1454     Document Type: Article

References (46)

1. Dorman JS, LaPorte RE, Kuller LH, Cruickshanks KJ, Orchard TJ, Wagener DK, Becker DJ, Cavender DE, Drash AL: The Pittsburgh Insulin-Dependent Diabetes Mellitus (IDDM) Morbidity and Mortality Study: mortality results. Diabetes 33:271-277, 1984
2. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR: Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59:750-755, 1987
3. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T: Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without nephropathy: incidence and risk factors. Diabetologia 30:144-148, 1987
4. Haffner SM, Stern MP, Rewers M: Diabetes and atherosclerosis: epidemiological considerations. In Diabetes and Atherosclerosis. Molecular Basis and Clinical Aspects. Draznin B, Eckel RH, Eds. New York, Elsevier Science, 1993, p. 229-254
5. Borch-Johnsen K, Kreiner S: Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ 294:1651-1654, 1987
6. Christlieb AR, Warram JH, Krolewski AS, Busick EJ, Ganda OP, Asmal AC, Soeldner JS, Bradley RF: Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics. Diabetes 30:90-96, 1981
7. Lloyd CE, Kuller LH, Becker DJ, Ellis D, Wing RR, Orchard TJ: Coronary artery disease in IDDM: gender differences in risk factors, but not risk. Arterioscler Thromb Vasc Biol 16:720-726, 1996
8. Koivisto VA, Stevens LK, Mattock MB, Ebeling P, Stephenson J, Idzior-Walus B, EURODIAB IDDM Complications Study Group: cardiovascular disease and its risk factors in IDDM in Europe. Diabetes Care 19:689-697, 1996
9. Orchard TJ, Stevens LK, Forrest KY-Z, Fuller JH: Cardiovascular disease in IDDM: similar rates, but different risk factors in the United States compared with Europe. Int J Epidemiol 27:976-983, 1998
10. Orchard TJ: Dyslipoproteinemia and diabetes. Endocrinol Metabol Clin North Am 19:361-380, 1990
11. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989
12. Lyons TJ: Lipoprotein glycation and its metabolic consequences. Diabetes 41:67-73, 1992
13. Lyons TJ: Oxidized low density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes? Diabet Med 8:411-419, 1991
14. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, Kuller LH: The prevalence of complications in insulin dependent diabetes mellitus by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study. II. Diabetes 39:1116-1124, 1990
15. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Ellis D, LaPorte RE, Kuller LH, Wolfson S, Drash AL: Factors associated with the avoidance of severe complications after 25 years of insulin dependent diabetes mellitus: Pittsburgh Epidemiology of Diabetes Complications Study. I. Diabetes Care 13:741-747, 1990
16. Orchard TJ, CCSP: Validation of coronary heart disease mortality data: the Community Cardiovascular Surveillance Project Pilot (Abstract). Am Heart Assoc Cardiovasc Dis Epidemiol Newsletter no. 46, 1985
17. Virella G, Virella I, Leman RB, Pryor MB, Lopes-Virella MF: Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int J Clin Lab Res 23:95-101, 1993
18. Virella G, Kilpatrick JM, Chenais F, Fudenberg HH: Isolation of soluble immune complexes from human serum: combined use of polyethylene glycol precipitation, gel filtration, and affinity chromatography on protein A-sepharose. Meth Enzymol 74:644-663, 1981
19. Mironova M, Virella G, Virella-Lowell I, Lopes-Virella MF: Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls. Clin Immunol Immunopathol 85:73-82, 1997
20. Lopes-Virella MF, Sherer GK, Lees AM, Wohltmann H, Mayfield R, Sagel J, LeRoy EC, Colwell JA: Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia 22:430-436, 1982
21. Beck AT, Garbin MG: Psychometric properties of the Beck Depression Inventory: 25 years of evaluation. Clin Psychol Rev 8:77-100, 1988
22. Borhani NO, Kass EH, Langford HG, Payne GH, Remington RD, Stamler J: The hypertension detection and follow-up program. Prev Med 5:207-215, 1976
23. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475, 1974
24. Bucolo G, David H: Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19:476-482, 1973
25. 2+ quantitation of high density lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples. Clin Chem 24: 900-904, 1978
26. National Institutes of Health and Dept of Health: Lipid Research Clinics Program. Washington, D.C., U.S. Government Printing Office, 1975
27. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
28. Cruickshanks KJ, Orchard TJ, Becker DJ: The cardiovascular risk profile of adolescents with insulin-dependent diabetes mellitus. Diabetes Care 8: 118-124, 1985
29. Mendoza SG, Zerpa A, Carrassco H, Colmenares O, Rangel A, Gartside PS, Kashyap ML: Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. Artery 12:1-23, 1983
30. Ellis D, Buffone GJ: New approach to evaluation of proteinuric states. Clin Chem 23:666-670, 1977
31. Van Rood JJ: Microlymphocytotoxicity method. In NIAID Manual of Tissue Typing Techniques. Ray JJ, Ed. Bethesda, MD, National Institutes of Health, 1980, p. 104
32. Ellis D, Coonrod BA, Dorman JS, Kelsey SF, Avner ED, Orchard TJ: Choice of urine predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus. Am J Kidney Dis 13:321-328, 1989
33. Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, Finardi G, Bellomo G: LDL oxidation in patients with severe carotid atherosclerosis: a study on in vitro and in vivo oxidation markers. Atheroscler Thromb Vasc Biol 14:1892-1898, 1994
34. Bergmark C, Wu R, DeFaire U, Lefvert AK, Swedenborg J: Patients with early-onset peripheral vascular disease have increased level of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol 15:441-445, 1995
35. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL: Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339:883-887, 1992
36. Puurunen M, Manttari M, Manninen V, Tenkanen L, Alfthan G, Ehnholm C, Vaarala O, Aho K, Palosuo T: Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med 154:2605-2609, 1994
37. Bellomo G, Maggi E, Poli M, Agosta FG, Bolatti P, Finardi G: Auto-antibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes 44:60-66, 1995
38. Korpinen E, Ackerblom HK, Groop PH, Vaarala O: Immune response to glycated and oxidized LDL in IDDM patients with and without renal disease. Diabetes Care 20:1168-1171, 1997
39. Lopes-Virella MF, Virella G: Immune mechanisms of atherosclerosis in diabetes mellitus. Diabetes 41:86, 1992
40. Gaziano JM, Hennekens CH, Ben-Yehuda O, Stampfer MJ, Witzum JL, Reaven PO: Levels of antibodies to an epitope of oxidized LDL and risk of myocardial infarction (MI) in the Physicians' Health Study (Abstract). Circulation 96:I-337A, 1997
41. Festa A, Kopp HP, Schernthaner G, Menzel EJ: Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia 41:350-356, 1998
42. Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witztum JL: Glycosylation of LDL enhances CE synthesis in human monocyte-derived macrophages. Diabetes 37:550-557, 1988
43. Quinn MT, Parthasarathy S, Fong LG, Steinberg D: Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A 84: 2995-2998, 1987
44. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM: Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85:1260-1266, 1990
45. Emmerich J, Bruckert E, Delaney F, Thomas D, Richard JL: Relation entre HDL-cholesterol et maladies cardivasculaires. Arch Mal Coeur Vaiss 85 (Suppl. 3):21-28, 1992
46. Maser RE, Wolfson SK, Stein EA, Drash AL, Becker DJ, Dorman JS, Ellis D, Orchard TJ: Cardiovascular disease and arterial calcification in insulin dependent diabetes mellitus: interrelationships and risk factor profiles. Pittsburgh Epidemiology of Diabetes Complications Study. VI. Arterioscler Thromb Vasc Biol 11:958-965, 1991